
Bristol-Myers Squibb
Bristol-Myers Squibb in Fortune Rankings
- About
- Great Place to Work
- Earnings Reports
Bristol-Myers Co. and Squibb Corp. merged in 1989 to form what’s now one of the world’s largest pharmaceutical companies. Bristol-Myers Squibb develops, licenses, manufactures, and delivers biopharmaceutical products for the treatment and management of diseases including HIV/AIDS, cancer, blood disorders, and cardiovascular and fibrotic conditions.

Courtesy of Bristol Myers Squibb
- Company Information
- World's Most Admired Companies
- Best Companies To Work For Europe
- America's Most Innovative Companies
- Key Financials (last Fiscal Year)
- Profit Ratios
- Earnings Per Share (last Fiscal Year)
- Total Return
- Updated:7/28/26
- Country/Territory:U.S.
- Headquarters:Princeton, N.J.
- Industry:Pharmaceuticals
- CEO:Christopher S. Boerner
- Website:https://www.bms.com
- Ticker:BMY
- Company type:Public
- Revenues ($M):$48,194
- Profits ($M):$7,054
- Market value ($M):$121,177
- Number of employees:32,500
Market value as of July 13, 2026.
- Sector:Natural resources
- Industry:Pharmaceuticals
- Current All-Star Rank:-
- Previous All-Star Rank:-
- Industry Rank:9
- Previous Industry Rank:7
- Overall Score:6.92
- Innovation:7
- People Management:11
- Use of Corporate Assets:11
- Social Responsibility:8
- Quality of Management:8
- Financial Soundness:11
- Long-Term Investment Value:9
- Quality of Products/Services:8
- Global Competitiveness:8
- Sector:Health Care
- CEO/Top executive:Christopher S. Boerner
- Group headquarters:U.S.
- HQ location:U.S.
- GPTW national list:Greece, Italy, Portugal, Spain
- Woman CEO:no
- Number of Years on List:2
- Sector:Health Care
- Strongest Dimension:Culture innovation
- Years on list:2
- Previous rank:-
- State:New Jersey
- $ Millions% change
- Revenues ($M):$48,194-0.2%
- Profits ($M):$7,054-
- Assets ($M):$90,038-
- Total Stockholder Equity ($M):$18,473-
- Profit as % of Revenues:14.6%
- Profits as % of Assets:7.8%
- Profits as % of Stockholder Equity:38.2%
- Earnings Per Share ($):3.50
- EPS % Change (from prior fiscal year):-
- EPS % Change (5 year annual rate):-
- EPS % Change (10 year annual rate):14%
- Total Return to Investors (last year):0.3%
- Total Return to Investors (5 year, annualized):1.1%
- Total Return to Investors (10 year, annualized):1%
Bristol-Myers Squibb stock chart
Bristol-Myers Squibb in Fortune Rankings
- Fortune 500
- Fortune Global 500
- America's Most Innovative Companies
- Fortune 100 Best Companies To Work For – Europe
- Fortune Sector Leaders: Health Care
- World's Most Admired Companies
- Fortune Modern Board 25
- World’s 25 Best Workplaces
